Sort by
Medicine and Dentistry
Oropharynx Squamous Cell Carcinoma
87%
Oropharynx Carcinoma
61%
Head and Neck Cancer
54%
HPV-positive Oropharyngeal Cancer
40%
Neurinoma
40%
Neoplasm
31%
Overall Survival
28%
Oral Cavity
28%
Recurrent Disease
28%
Neck
28%
Tobacco Use
27%
Alveolar Ridge
27%
Neurofibromatosis Type II
26%
Carcinogenesis
23%
Tumor
21%
Dental Health
20%
Minimal Residual Disease
20%
Celecoxib
20%
Socioeconomic Status
20%
Cellular Infiltration
20%
Veterans Affairs
20%
Cancer
20%
Health Care
20%
T Cell
20%
Wart Virus
20%
Sensorineural Hearing Loss
20%
Squamous Cell Carcinoma
20%
Oral Cancer
20%
Cancer Treatment
20%
Phosphotransferase
20%
Robot-Assisted Surgery
20%
Lymph Duct
20%
Proteasome
20%
University Student
20%
Transcriptomics
20%
Sentinel Lymph Node Biopsy
20%
Systematic Review
20%
Lymph Node
20%
Meta-Analysis
20%
Skin Carcinoma
20%
Diseases
18%
National Health and Nutrition Examination Survey
16%
Cancer Epidemiology
16%
Disease Free Survival
13%
Recurrence Free Survival
13%
Progression Free Survival
12%
Cohort Analysis
10%
Alcohol Consumption
10%
Oropharynx
10%
Sequela
10%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Head-and-neck Cancer
49%
HPV-related Oropharyngeal Cancer
43%
Never-smokers
28%
Tobacco Use
22%
Alveolar Ridge
22%
Neurofibromatosis Type 1 (NF-1)
20%
Cyclooxygenase-2
20%
Celecoxib
20%
Pack-years
20%
Survival Disparities
20%
Cancer Incidence
20%
Drinkers
20%
Dental Health
20%
High-risk Human Papillomavirus (HR-HPV)
20%
Murine Model
20%
Treatment De-escalation
20%
Smoking History
20%
Malignancy
20%
Lymphatic Fluid
20%
Veterans Affairs Healthcare System
20%
Lymph
20%
Minimal Residual Disease
20%
Schwannoma
20%
Cancer-specific Survival
20%
Survival Benefit
20%
Genome Analysis
20%
Student Outreach
20%
T Cell Infiltration
20%
National Trends
20%
Oral Cavity Cancer
20%
Genetic Engineering
20%
Cancer Treatment
20%
Risk Factors
20%
Transoral Robotic Surgery
20%
Neurofibromatosis Type 2
20%
After Surgery
20%
Socioeconomic Status
20%
Cancer Outcomes
20%
Sudden Sensorineural Hearing Loss (SSNHL)
20%
Cancer Genomics
20%
Cancer Transcriptomics
20%
HPV-related Cancers
20%
Systematic Meta-analysis
20%
Clinically Node-negative
20%
Regional Lymph Nodes
20%
Sentinel Lymph Node Biopsy
20%
Squamous Cell Carcinoma of Head
20%
Head-and-neck
20%
Cutaneous Squamous Cell Carcinoma (cSCC)
20%